Laboratory Analysis of Homeopathic Teething Tablets
FDA has completed testing of homeopathic teething tablets labeled as containing belladonna and other ingredients and marketed by CVS and Hyland’s Inc. Our testing found that the belladonna alkaloids (atropine and scopolamine) content and coffea cruda (caffeine) content is not uniform among the manufactured tablets. FDA analysis found the levels of atropine and scopolamine in some of the CVS tablets and the levels of scopolamine in some of the Hyland’s tablets far exceeded the amount stated on the products’ labels.
Inconsistency in levels of belladonna, a toxic substance, signals a poorly controlled manufacturing process and poses an unnecessary risk to infants and children under two years of age.
Certain homeopathic teething products are manufactured to contain a very small amount of belladonna and other ingredients. Ordinarily, such low levels would not be readily detected by even highly sensitive testing methods, including those used by FDA at its laboratories.
Therefore, FDA’s analysis should not have found any detectable belladonna in these products.
The following tables highlight FDA’s laboratory data:
Table 1: Homeopathic teething tablets manufactured by Raritan Pharmaceuticals
FDA Sample Number | Product Name | Lot Number | Product Description | Label Declarations |
---|---|---|---|---|
816291 | CVS Health Homeopathic Infants’ Teething Tablets | 43436 | 1 bottle of 135 Tablets |
Belladonna 12X HPUS* |
910933 | CVS Health Homeopathic Infants’ Teething Tablets | 41116 | 1 bottle of 135 Tablets |
Belladonna 12X HPUS |
* Homeopathic Pharmacopoeia of the United States
Table 2: Liquid Chromatography/Mass Spectrometry results for teething tablets manufactured by Raritan Pharmaceuticals
An ion mobility spectrometer was used to screen 1088 CVS branded teething tablets for the presence of belladonna alkaloids. Teething tablets testing positive for belladonna alkaloids by ion mobility were further analyzed using liquid chromatography/mass spectrometry.
FDA Sample Number | Number of Tablets Analyzed | Identified | Belladonna alkaloid – Scopolamine | Belladonna alkaloid – Atropine |
---|---|---|---|---|
Levels/Range | Levels/Range | |||
816291 | 34 tablets | 1 tablet | 357 | Below Limit of Quantification |
1 tablet | Below Limit of Quantification | Below Limit of Quantification | ||
910933 | 8 tablets | 1 tablet | 64 | Below Limit of Quantification |
1 tablet | Below Limit of Quantification | Below Limit of Quantification | ||
1 tablet | Below Limit of Quantification | 1100 | ||
1 tablet | Below Limit of Quantification | 53 | ||
1 tablet | Below Limit of Quantification | 380 | ||
1 tablet | 390 | Below Limit of Quantification | ||
1 tablet | Below Limit of Quantification | 77 | ||
1 tablet | Below Limit of Quantification | 75 |
Table 3: Homeopathic teething tablets manufactured by Standard Homeopathic Company
FDA Sample Number | Product Name | Lot Number | Product Description | Label Declarations |
---|---|---|---|---|
969837 | Hyland’s Baby Natural Relief Nighttime Teething Tablets | A67116 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
969838 | Hyland’s Baby Natural Relief Nighttime Teething Tablets | A31316 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
969839 | Hyland’s Baby Natural Relief Nighttime Teething Tablets | B66915 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
969840 | Hyland’s Baby Natural Relief Teething Tablets | B96615 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
969841 | Hyland’s Baby Natural Relief Teething Tablets | B73615 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
969842 | Hyland’s Baby Natural Relief Teething Tablets | A29916 | 1 bottle of 135 Tablets | Belladonna 12X HPUS |
Table 4: Liquid Chromatography/Mass Spectrometry results for teething tablets manufactured by Standard Homeopathic Company
FDA Sample Number | Number of Tablets Analyzed | Belladonna alkaloid – Scopolamine | Coffea Cruda – Caffeine | ||
---|---|---|---|---|---|
Identified | Levels/Range (nanograms) | Identified | Levels/Range | ||
969837 | 137 tablets* | 1 tablet | Below Limit of Quantification | 1 tablet | 5.7 |
136 tablets | 1 – 2.1 | ||||
969838 | 20 tablets | Not Detected | - | 20 tablets | 1.3 – 2 |
969839 | 138 tablets | 66 tablets | 0.1 – 7.2 | 138 tablets |
0.96 – 2.8 |
25 tablets | Below Limit of Quantification | ||||
969840 | 139 tablets | 1 tablet | 11.6 | 139 tablets |
|
1 tablet | 13.1 | ||||
1 tablet | 12.2 | ||||
1 tablet | 25.1 | ||||
1 tablet | 53.4 | ||||
1 tablet | 14.5 | ||||
57 tablets | 0.1 – 6.7 | ||||
19 tablets | Below Limit of Quantification | ||||
969841 | 20 tablets | Not Detected | - | 20 tablets | 1.2 – 1.9 |
969842 | 20 tablets | Not Detected | - | 20 tablets | 1.2 – 2 |
*Some bottles contained more tablets than labeled.